DCF Advisers’s Sanofi SNY Stock Holding History

DCF Advisers’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$265K	Buy	+5,500	New	+$256K	0.07%	80

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

DCF Advisers's SNY Position: Q1 2026 in Review

DCF Advisers sold out of Sanofi (SNY) in Q1 2026, closing a stake of 21,000 shares — an estimated $979K sold.

DCF Advisers first reported a position in SNY in Q3 2022 and held it in 11 quarters. The position peaked at $1.02M in Q4 2025. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

DCF Advisers reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
DCF Advisers sold 21,000 Sanofi shares in Q1 2026, an estimated $979K.
DCF Advisers first reported a position in Sanofi in Q3 2022 and held it in 11 quarters.
DCF Advisers's Sanofi position peaked at $1.02M in Q4 2025.
739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.